Hospital.Help

Bethesda/Maryland – The antiviral drug tecovirimat, the only approved drug against orthopoxviruses, was found to have no effect against Mpox viruses of clade Ib, which are responsible for the current epidemic in some African countries, in a randomized study in the Congo. However, the fatality rate of the disease was lower than feared. Publication of the results is still pending. The PALM007 study was launched in October 2022 by the US National…